Monoamine Oxidase Inhibitors

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Core Mechanism: Monoamine oxidase inhibitors (MAOIs) function by preventing the breakdown of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) in the central and peripheral nervous systems (Note: the exact enzymatic mechanism is foundational medical knowledge outside the provided text). In overdose, the massive accumulation of these neurotransmitters precipitates a profound "hyperadrenergic storm".
• The Delayed Cliff: Unlike many other rapid-acting toxins, the onset of MAOI toxicity is notoriously gradual and delayed, sometimes taking up to 24 hours to manifest.
• The Abrupt Crash: Despite the delayed onset, clinical deterioration is not a slow curve. Once the threshold is crossed, patients experience the abrupt development of intractable seizures, coma, respiratory insufficiency, and catastrophic cardiovascular collapse.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Initial Stabilization: Establish at least one (preferably large-bore) peripheral IV line and place the patient on continuous cardiac monitoring immediately.
• Resuscitation Goals: There is no known antidote for MAOI toxicity. Emergency management is strictly directed toward aggressive supportive care, securing the airway in the event of abrupt respiratory insufficiency or coma, and early treatment of complications like seizures or cardiovascular collapse.
• Targeted Complication Management: You must actively anticipate and manage hyperadrenergic surges followed by cardiovascular collapse, prioritizing ABCs and treating emerging dysrhythmias symptomatically.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• The "Can't-Miss" Mimics: The clinical presentation of MAOI toxicity frequently mimics other hypermetabolic and hyperadrenergic states. The differential diagnosis includes:
• Sympathomimetic intoxication: Amphetamines, cocaine, MDMA, cathinone, methylphenidate.
• Toxic Syndromes: Serotonin syndrome, malignant hyperthermia, antimuscarinic toxicity.
• Medical Conditions: Pheochromocytoma, hyperthyroidism, spontaneous hypertensive crisis, hypoglycemia, heatstroke.
• Dietary: Tyramine reaction (the classic MAOI food-drug interaction).
• Prioritized Diagnostic Workup:
• Core Labs: You must obtain specific laboratory studies designed to identify the lethal secondary complications of MAOI toxicity. Specifically, evaluate for hyperkalemia, metabolic acidosis, and rhabdomyolysis.
• Order a basic metabolic panel (BMP), serum creatine kinase (CK), and an arterial or venous blood gas.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• The Electrocardiogram (ECG): All patients require immediate and continuous cardiac monitoring. The emergency physician must evaluate the ECG for:
• Tachyarrhythmias and ischemic changes secondary to the profound hyperadrenergic storm.
• Signs of hyperkalemia (e.g., peaked T-waves, PR prolongation, or QRS widening), which is a specific, lethal metabolic complication associated with this overdose.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• The 24-Hour Rule: The absolute standard of care for MAOI overdoses dictates that even completely asymptomatic patients must be admitted (typically to the ICU) and monitored for a minimum of 24 hours before discharge.
• High-Risk Patient Profiling: For any given dose of an MAOI, toxicity is predicted to be significantly greater and more lethal in children, the elderly, and patients with co-ingestants or significant underlying medical problems.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• The Premature Discharge Pitfall: Pitfall: Discharging an asymptomatic patient 6 to 12 hours after an MAOI ingestion (confusing the observation rule with that of typical SSRIs or TCAs). Critical Action: Board examiners mandate that you never discharge an MAOI overdose prematurely. The onset of toxicity can be delayed up to 24 hours, after which the patient can abruptly develop seizures, cardiovascular collapse, and die.
• The Dietary/Medication Trap: Critical Action: Even if the patient is cleared after 24 hours, strict dietary (tyramine) and medication restrictions must be reinforced to prevent delayed hypertensive crises.

7. MCQ MASTERCLASS (Written Exam Tips)

• Buzzword: "Asymptomatic patient after an intentional ingestion of an MAOI (e.g., tranylcypromine, phenelzine)." Exam Answer: Admit to the intensive care unit for a minimum of 24 hours of observation.
• Distractor: An exam option will suggest observing the asymptomatic MAOI patient for 6 hours or 12 hours and then discharging home. Correction: This is a lethal trap; 24 hours is the strict minimum.
• High-Yield Fact: MAOI toxicity is uniquely characterized by a "delayed but abrupt" clinical course. Symptoms brew silently for hours, but the onset of seizures, respiratory failure, and cardiovascular collapse is sudden.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• The Initial Resuscitation: "Although this patient is currently asymptomatic following their MAOI ingestion, I recognize that the onset of life-threatening toxicity can be delayed for up to 24 hours. I will place at least one large-bore peripheral IV, place the patient on a continuous cardiac monitor, and order labs specifically looking for hyperkalemia, metabolic acidosis, and rhabdomyolysis."
• The Disposition: "Because the abrupt development of seizures, coma, hyperadrenergic storm, and cardiovascular collapse is possible up to a day after ingestion, I am admitting this patient to the intensive care unit for a strict minimum of 24 hours of continuous observation, regardless of their currently normal vital signs."
• The Counseling: "Prior to discharge tomorrow, I will ensure the patient is counseled on strict dietary tyramine and medication restrictions to prevent a fatal secondary reaction."